HomeCompany NewsUS FDA approves Urogen's bladder cancer drug Company NewsHealthIsraelMiddle EastN2:BIODRGN2:CNCERN2:HECAN2:MEDREGN2:MRCHN2:PHMRN2:PUBLsubj:04002006subj:04016000subj:07000000subj:07001004subj:07013000subj:13019000 US FDA approves Urogen’s bladder cancer drug June 12, 2025 0 50 Share FacebookTwitterPinterestWhatsApp Signage is seen outside of FDA headquarters in White Oak, Maryland (Reuters) -The U.S. Food and Drug Administration has approved Urogen Pharma's drug to treat a type of bladder cancer, the regulator said on Thursday. (Reporting by Padmanabhan Ananthan and Kamal Choudhury in Bengaluru; Editing by Leroy Leo) Hi, I'm Reuters Share FacebookTwitterPinterestWhatsApp Previous articleUS sues New York over law blocking immigration enforcement near courtNext articleTunisia sentences prominent opposition figure Abir Moussi to two years in prison RELATED ARTICLES Advocacy Groups Tunisia imposes one-month suspension on migrant-rights group October 27, 2025 Africa Sudanese force’s capture of Darfur city could entrench country’s split October 27, 2025 America Turkey signs deal to buy 20 Eurofighters from Britain for 8 billion pounds October 27, 2025 Most Popular Trump to talk trade, security with Japan’s new leader Takaichi October 27, 2025 Hurricane Melissa begins lashing Jamaica as ‘catastrophic’ Category 5 storm October 27, 2025 Tunisia imposes one-month suspension on migrant-rights group October 27, 2025 Ivory Coast’s Ouattara secures fourth term with landslide election win October 27, 2025 China fills US void at ASEAN Summit with push for trade multilateralism October 27, 2025 Sudanese force’s capture of Darfur city could entrench country’s split October 27, 2025 Load more